Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
ID: 357198Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Social Disconnection and Suicide Risk in Late Life," aimed at exploring the relationship between social isolation and suicide risk among older adults. This initiative encourages research projects that investigate neurobiological and environmental mechanisms linking social disconnection and loneliness to increased suicidal thoughts and behaviors, with a focus on developing interventions to enhance social connections and prevent suicide in late life. Given the rising suicide rates in this demographic, the NIH emphasizes the urgent need for targeted research, particularly addressing disparities across various populations. Selected projects may receive funding of up to $275,000 over two years, with applications accepted starting January 2025 and a submission deadline of September 7, 2026. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-066.html.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Institutes of Health (NIH) is releasing a funding opportunity aimed at investigating the connection between social disconnection and suicide risk in older adults. Specifically, the Social Disconnection and Suicide Risk in Late Life initiative encourages exploratory and developmental research (R21 grants) that identifies mechanisms by which social isolation increases suicide risk and how social integration may provide protective effects. The NOFO emphasizes the need for multi-level analysis, including neurobiological, behavioral, and environmental factors that contribute to this public health issue. With suicide rates rising significantly in this demographic, there is an urgent need for targeted interventions-though the evidence base currently remains thin. The funding seeks proposals that examine factors such as the impact of social disconnection on suicidality and disparities across different populations, including racial, gender, and socioeconomic dimensions. Selected projects may receive up to $275,000 over two years, with applications due from January 2025 onwards. Overall, the initiative aims to enhance understanding of critical intervention targets that can improve mental health outcomes among older adults facing suicide risk.
    Similar Opportunities
    Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)" aimed at stimulating research on the relationship between social disconnection, including both objective social isolation and perceived loneliness, and suicide risk among older adults. The initiative seeks applications for research projects that explore neurobiological and environmental mechanisms contributing to suicidal thoughts and behaviors in late life, with a focus on developing and testing interventions to enhance social connection and prevent suicide. This funding opportunity is particularly significant given the rising suicide rates in the aging population, exacerbated by social isolation, and encourages innovative research methodologies to address these mental health challenges. Interested applicants can find more details and submit their proposals by the closing date of September 7, 2026, and should direct inquiries to grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-238.html.
    Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Social Disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)" aimed at supporting research on the relationship between social disconnection and suicide risk among older adults. This initiative seeks innovative projects that explore neurobiological, behavioral, and environmental mechanisms influencing social isolation and its impact on suicidal thoughts and behaviors, with an emphasis on promoting health equity and developing interventions to enhance social support. The grant provides a maximum funding amount of $275,000 over a two-year period, with applications due by September 7, 2026. Interested applicants can find more information and application instructions at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for research projects focused on "Social Disconnection and Suicide Risk in Late Life," aimed at understanding the relationship between social isolation and suicidal behaviors among older adults. The initiative encourages applications that explore neurobiological, behavioral, and environmental factors contributing to this issue, with an emphasis on developing interventions to prevent late-life suicide. This funding reflects a critical need for evidence-based strategies to address the rising rates of suicide in older populations, considering health equity and disparities in access to care. Interested applicants can find more information and submit proposals by the deadline of September 7, 2026, and should direct inquiries to grantsinfo@nih.gov.
    Research Opportunities in Crisis Response Services for Suicide Prevention
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce a funding opportunity for research focused on crisis response services aimed at suicide prevention. This initiative seeks to examine the effectiveness and implementation of crisis response practices, with an emphasis on improving the quality and outcomes of interventions in real-world settings, while considering various psychosocial factors and health disparities. The total estimated funding for this program is $2 million, with approximately five awards expected to be granted. Interested applicants, particularly small businesses with expertise in crisis response and suicide prevention, are encouraged to prepare for this opportunity, with the anticipated synopsis posting date on September 8, 2025, and a closing date for applications on October 8, 2025. For further inquiries, potential applicants can contact Dr. Jennifer Humensky at jennifer.humensky@nih.gov or by phone at 301-480-1265.
    Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Schizophrenia and Related Disorders During Mid- to Late-Life" (PAR-24-026), aimed at advancing research on the onset and progression of schizophrenia and related disorders in individuals aged 35 and older. This initiative seeks to promote high-risk exploratory and developmental projects that investigate neurobiological, psychosocial, and environmental factors contributing to these disorders, with a particular emphasis on addressing health disparities among minority and aging populations. The program offers a maximum funding amount of $275,000 over two years, with applications due by November 16, 2023, for the initial cycle. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Schizophrenia and Related Disorders During Mid- to Late-Life," aimed at advancing research on the emergence and trajectory of schizophrenia and related disorders in individuals aged 35 and older. This initiative seeks to identify biological, psychosocial, and environmental mechanisms affecting this population to develop effective prevention and treatment strategies, addressing a critical gap in mental health research. The funding utilizes the R01 grant mechanism, with applications accepted starting January 5, 2025, and a project period of up to five years. Eligible applicants include a wide range of institutions and organizations, and inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov. The application deadline is September 7, 2026.
    Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care." This initiative aims to solicit research applications focused on developing and testing effective provider-level interventions and tools that enhance the delivery of evidence-based suicide prevention services, including risk assessment and therapeutic interventions. The program is critical for improving the competence and fidelity of care in various therapeutic settings, ultimately contributing to better mental health outcomes. The estimated total funding for this program is $5 million, with approximately five awards expected. Interested applicants can reach out to Dr. Stephen O'Connor at stephen.oconnor@nih.gov or call 301-480-8366 for further information. The anticipated synopsis posting date is August 17, 2025, with applications expected to close by October 17, 2025, and project start dates projected for July 1, 2026.
    Pilot Effectiveness Trials of Peer Support Services for Suicide Prevention
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity titled "Pilot Effectiveness Trials of Peer Support Services for Suicide Prevention," aimed at soliciting research applications focused on the preliminary effectiveness of peer support interventions in reducing suicide risk. The initiative seeks to evaluate the feasibility, acceptability, and potential effectiveness of these interventions in clinical and community settings, while also gathering preliminary data necessary for larger-scale trials. This grant, categorized under health funding activities, has an estimated total program funding of $3 million and is open to small businesses with relevant expertise. Interested applicants should note that applications are not currently being solicited, but they are encouraged to prepare collaborative projects ahead of the estimated synopsis posting on August 28, 2025, with a closing date for submissions anticipated on October 28, 2025. For further inquiries, potential applicants can contact Stephen O'Connor, Ph.D., at stephen.oconnor@nih.gov or by phone at 301-480-8366.
    Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)" aimed at advancing research on schizophrenia and related disorders in individuals aged 35 and older. This initiative seeks to explore the mechanisms, trajectories, and outcomes of these disorders, with a focus on identifying targets for prevention and treatment interventions, particularly emphasizing the inclusion of diverse research teams and individuals with lived experience. The funding is available through the R01 grant mechanism, with applications due by September 7, 2026, and interested applicants are encouraged to adhere strictly to the application guidelines and contribute data to the National Institute of Mental Health Data Archive. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-023.html.
    Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for exploratory research on schizophrenia and related disorders in individuals aged 35 and older, through the R21 grant mechanism. This initiative aims to enhance understanding of the onset, trajectory, and outcomes of these disorders in mid- to late-life, encouraging innovative studies that identify biological, behavioral, and environmental risk factors, as well as potential interventions. The funding, which can reach up to $275,000 over a maximum of two years, is crucial for addressing health disparities faced by older adults with these disorders and promoting novel solutions for their care. Applications are due between January 2025 and October 2026, and interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.